Hersh J, Crystal R G, Bewig B
Division of Pulmonary and Critical Care Medicine, New York Hospital-Cornell Medical Center, NY 10021.
Gene Ther. 1995 Mar;2(2):124-31.
To regulate gene expression following adenovirus-mediated gene transfer, a strategy was devised utilizing co-infection with two separate adenovirus vectors designed such that the product of one vector modulated the promoter of the second vector. To evaluate this strategy, AdEGR1.TNF, an adenovirus expressing tumor necrosis factor-alpha (TNF) under the control of the early growth response 1 (EGR1) promoter, was used to regulate a transcription unit in AdIL8.beta gal, an adenovirus vector in which the TNF sensitive interleukin-8 (IL-8) promoter drives the expression of beta-galactosidase (beta-gal). Following infection of HS24 cells with AdIL8.beta gal, addition of TNF to the culture induced the expression of beta-gal. Infection of HS24 cells with AdEGR1.TNF resulted in a dose-dependent secretion of TNF. Little beta-gal was produced following co-infection of the cells with the control vector AdCMV.Null (expressing no specific gene) and AdIL8.beta gal. In contrast, co-infection with AdIL8.beta gal and AdEGR1.TNF demonstrated, for a given dose of AdIL8.beta gal, increasing amounts of beta-gal expression dependent on the dose of AdEGR1.TNF. This model suggests control of gene expression in adenovirus-mediated gene transfer can be regulated by utilizing a promoter-gene expression cassette in one vector that modulates the expression of a promoter-gene expression cassette in a second vector.
为了在腺病毒介导的基因转移后调节基因表达,设计了一种策略,即利用两种单独的腺病毒载体共同感染,这两种载体的设计使得一种载体的产物能够调节第二种载体的启动子。为了评估该策略,使用了AdEGR1.TNF,一种在早期生长反应1(EGR1)启动子控制下表达肿瘤坏死因子-α(TNF)的腺病毒,来调节AdIL8.βgal中的转录单元,AdIL8.βgal是一种腺病毒载体,其中TNF敏感的白细胞介素-8(IL-8)启动子驱动β-半乳糖苷酶(β-gal)的表达。用AdIL8.βgal感染HS24细胞后,向培养物中添加TNF可诱导β-gal的表达。用AdEGR1.TNF感染HS24细胞会导致TNF的剂量依赖性分泌。用对照载体AdCMV.Null(不表达特定基因)和AdIL8.βgal共同感染细胞后,几乎不产生β-gal。相反,对于给定剂量的AdIL8.βgal,用AdIL8.βgal和AdEGR1.TNF共同感染表明,β-gal的表达量会随着AdEGR1.TNF剂量的增加而增加。该模型表明,在腺病毒介导的基因转移中,基因表达的控制可以通过利用一种载体中的启动子-基因表达盒来调节第二种载体中启动子-基因表达盒的表达来实现。